<unk>  is an antineoplastic agent that is FDA approved for the treatment of myelodysplastic syndromes (MDS).   Common adverse reactions include neutropenia, thrombocytopenia, anemia and pyrexia.
Decitabine
Ibacitabine
Lafutidine
Azacytidine
Trifluridine
Floxuridine
Idoxuridine
Vidarabine